TG Therapeutics Inc
(FRA:NKB2)
€
46.9
-2 (-4.09%)
Market Cap: 7.22 Bil
Enterprise Value: 7.39 Bil
PE Ratio: 20.08
PB Ratio: 13.94
GF Score: 58/100 TG Therapeutics Inc (FRA:NKB2) Transcripts
- 1